Paul D. Rubin, Chief Officer of BioAge Labs BIOA, has filed 0 purchases and 6 sales on the open market. Over the past 12 months that comes to a net sale of $1.5M. The latest trade was on 04/01.

PR

PR

Paul D. Rubin

Chief Medical Officer

Company

BioAge Labs BIOA

First filing

25/02/20

Trades

28 trades

Buys / sales

0 / 6

12-month net buying

−$1.5M

Last trade

04/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
BioAge LabsBIOA	Open-market sale10b5-1 plan	04/01	04/03	8,820 sh	$17.81	$157,084.2	−100.0%
BioAge LabsBIOA	Open-market sale10b5-1 plan	03/02	03/03	7,433 sh	$20.30	$150,889.9	−100.0%
BioAge LabsBIOA	Open-market sale10b5-1 plan	02/02	02/03	7,433 sh	$18.75	$139,368.75	−100.0%
BioAge LabsBIOA	Open-market sale10b5-1 plan	01/02	01/06	7,433 sh	$12.85	$95,514.05	−100.0%
BioAge LabsBIOA	Open-market sale10b5-1 plan	25/12/09	25/12/11	18,000 sh	$12.00	$216,000	−100.0%
BioAge LabsBIOA	Open-market sale10b5-1 plan	25/12/04	25/12/05	68,897 sh	$10.19	$702,060.43	−100.0%